Skeletal homeostasis in tissue-engineered bone. (Q51836263)

13 April 2018

title

Skeletal homeostasis in tissue-engineered bone. (English)

1 reference

13 April 2018

author name string

Abraham Schneider

1

1 reference

13 April 2018

Juan M Taboas

2

1 reference

13 April 2018

Laurie K McCauley

3

1 reference

13 April 2018

Paul H Krebsbach

4

1 reference

13 April 2018

publication date

1 September 2003

1 reference

13 April 2018

Journal of Orthopaedic Research

published in

1 reference

13 April 2018

volume

21

1 reference

13 April 2018

issue

5

1 reference

13 April 2018

page(s)

859-864

1 reference

13 April 2018

Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

Stem cells in tissue engineering.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

Effects of interleukin-1 on bone turnover in normal mice

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

Anabolic actions of parathyroid hormone during bone growth are dependent on c-fos

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

Stimulation of new bone formation by direct transfer of osteogenic plasmid genes

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

Interleukin-1 represses COLIA1 promoter activity in calvarial bones of transgenic ColCAT mice in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

Ectopic bone formation by marrow stromal osteoblast transplantation using poly(DL-lactic-co-glycolic acid) foams implanted into the rat mesentery

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

Repair of craniotomy defects using bone marrow stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

Transgenic mouse models of metabolic bone disease

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

Effects of interleukin-1 alpha and cyclosporin A in vivo and in vitro on bone and lymphoid tissues in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

Parathyroid hormone is essential for normal fetal bone formation

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

Tissue-engineered bone regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

Multilineage potential of adult human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

A biodegradable polymer as a cytokine delivery system for inducing bone formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

Tissue engineers build new bone

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

A model for investigating the local action of bone-acting agents in vivo: effects of hPTH(1-34) on the secondary spongiosa in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

Bone resorption by osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

An overview of tissue engineered bone.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2803%2900042-1

7 January 2021

10.1016/S0736-0266(03)00042-1

Identifiers

DOI

1 reference

13 April 2018

PubMed ID

12919874

1 reference

13 April 2018